Search results for "influenza"
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
…he scale-up of upstream and downstream processes for the production of a cell based live attenuated influenza virus using single-use ReadyToProcess technology (Fig 1).
Introduction
Egg-ba…
Article
Concentration and Diafiltration of Cell-Derived, Live Influenza Virus Using 750 C Hollow Fiber Filter Cartridge
Cross flow filtration (CFF) is a technique extensively used in vaccine production and particularly in influenza vaccine manufacturing. In contrast to normal flow (dead-end) filtration (NFF), the fee…
Poster
Validation of the Production of Influenza Virus
This application note describes the validation of the single-use ReadyToProcess WAVE 25 rocking bioreactor system in production of influenza virus from Vero cells in microcarrier-based cultures. A 2…
Article
Validation of the production of influenza virus in ReadyToProcess WAVE™ 25 bioreactor system
This application note describes the validation of the single-use ReadyToProcess WAVE 25 rocking bioreactor system in production of influenza virus from Vero cells in microcarrier-based cultures. A 2…
Poster
Residual DNA analysis in influenza vaccine processing
In cell-based influenza vaccine production, the European Pharmacopoeia demands a host cell residual DNA concentration of less than 10 ng per dose. To reliably measure residual DNA in both process sa…
Article
Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions
…the need to invest in new vaccine technologies that can ensure national preparedness for a pandemic influenza or other diseases. Many other countries are focused on developing similar capabilities. T…
Article
EMA Invites Comments on New Guidance for Vaccine Development
The guidance covers the non-clinical and clinical requirements for the development of new influenza vaccines and aims to facilitate the prompt assessment of new vaccines. It follows the publication of…
Article
Novavax Reports on Two Vaccine Efficacy Studies
Novavax also reported on June 14, 2021, data from a co-administration study of NVX-CoV2373 and an approved influenza vaccine, which suggests simultaneous vaccination for COVID-19 and influenza may be …
Article
Biopharma Manufacturers Respond to Ebola Crisis
A main strategy is to explore whether drugs developed as countermeasures to influenza pandemics and other biological threats could be effective against Ebola. Biomedical development programs at the Na…
Article
Modern Manufacturing Key to More Effective Vaccines
By Jill Wechsler
A lethal influenza outbreak this past winter has spotlighted the importance of improving and accelerating vaccine discovery and production. Reports that this year…